HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer

HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer

Alberto Bretoni, Lucrezia Ferrario, Emanuela FogliaCentre for Health Economics, Social and Health Care Management, LIUC – Università Cattaneo, Castellanza, ItalyPurpose: To investigate the implications of the introduction of two hormonal therapies, abiraterone acetate + predniso...

Full description

Bibliographic Details
Main Authors: Bretoni A, Ferrario L, Foglia E
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
mCRPC
multidimensional assessment
economic evaluation
multicriteria decision analysis
hormonal therapies
MCDA
Online Access:https://www.dovepress.com/hta-and-innovative-treatments-evaluation-the-case-of-metastatic-castra-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/hta-and-innovative-treatments-evaluation-the-case-of-metastatic-castra-peer-reviewed-article-CEOR

Similar Items